69015 | pET-32a(+) DNA - Novagen

69015
No pudo obtenerse el precio
Minimum Quantity needs to be mulitiple of
Al finalizar el pedido Más información
Ahorró ()
 
Solicitar precio
Disponibilidad a confirmarDisponibilidad a confirmar
En existencia
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    Remaining : Will advise
      Se avisará
      Ver precios y disponibilidad
         CompararClick To Print This Page

      Overview

      Replacement Information

      Precios y disponibilidad

      Número de referenciaDisponiblidad Embalaje Cant./Env. Precio Cantidad
      69015-3
      Comprobando disponibilidad...
      Disponibilidad a confirmarDisponibilidad a confirmar
      En existencia
      Suspendido
      Cantidades limitadas disponibles
      Debe confirmarse disponibilidad
        Remaining : Will advise
          Se avisará

          10 μg
          Recuperando precio...
          No pudo obtenerse el precio
          Minimum Quantity needs to be mulitiple of
          Al finalizar el pedido Más información
          Ahorró ()
           
          Solicitar precio
          Description
          Overview The pET-32a(+) vector is designed for cloning and high-level expression of peptide sequences fused with the 109aa Trx•Tag™ thioredoxin protein (1). Cloning sites are available for producing fusion proteins also containing cleavable His•Tag® and S•Tag™ sequences for detection and purification. Note that the sequence is numbered by the pBR322 convention, so the T7 expression region is reversed on the vector map, TB122VM. The f1 origin is oriented so that infection with helper phage will produce virions containing single-stranded DNA that corresponds to the coding strand.

          The pET Vectors are supplied as purified plasmid DNA (10 µg). Each order of pET DNA also includes an Induction Control strain (supplied as a glycerol stock). Please contact technical service if you need additional information.




          Commercial use of this Product requires a commercial license from EMD Millipore Corporation. Commercial use shall include but not be limited to (1) use of the Product or its components in manufacturing; (2) use of the Product or its components to provide a service, information, or data to others in exchange for consideration; (3) use of the Product or its components (or any derivatives thereof) for therapeutic, diagnostic or prophylactic purposes (including as part of a device, chip, assay or other product); or (4) resale of the Product or its components, whether or not such Product or its components are resold for use in research. Nothing contained herein shall be deemed to represent or warrant that additional third party rights are not required for use of this Product.
          Catalogue Number 69015
          Brand Family Novagen®
          References
          References 1. LaVallie, E.R., DiBlasio, E.A., Kovacic, S., Grant, K.L., Schendel, P.F. and McCoy, J.M. (1993) Bio/Technology 11, 187–193.
          Product Information
          Vector family pET
          Applications
          Biological Information
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Shipped with Blue Ice or with Dry Ice
          Toxicity Standard Handling
          Storage ≤ -70°C
          Avoid freeze/thaw Avoid freeze/thaw
          Do not freeze No
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Ficha datos de seguridad (MSDS)

          Title

          Material Safety Data Sheet (MSDS)  

          Certificados de análisis

          CargoNúmero de lote
          69015

          Referencias bibliográficas

          Visión general referencias
          1. LaVallie, E.R., DiBlasio, E.A., Kovacic, S., Grant, K.L., Schendel, P.F. and McCoy, J.M. (1993) Bio/Technology 11, 187–193.

          Citas

          Título
        • Robertson, P.D., et al. 2008. Journal of Biological Chemistry 283, 3338.
        • Cai, M., et al. 2007. Journal of Biological Chemistry 282, 14525.
        • Dai, M., et al. 2007. Plant Physiology 144, 121.
        • Adam Joelsson, A., et al. 2007. Applied and Enviornmental Microbiology 73, 3742.
        • Wong, H.L., et al. 2007. Plant Cell 19, 4022.
        • Gyan, S., et al. 2006. Journal of Bacteriology 188, 7062.
        • Masin, M., et al. 2006. Journal of Biological Chemistry 281, 4100.
        • Oertelt, S., et al. 2006. Journal of Immunology 177, 1655.
        • Smith R.M., and Williams S.B., 2006. Proceedings of the National Academy of Sciences (USA) 103, 8564.
        • Suzuki, H., et al. 2006. Journal of Biological Chemistry 281, 30251.
        • Vercauteren, K., et al. 2006. Molecular and Cellular Biology 26, 7409.
        • Anjard, C., and Loomis, W.F., 2005. Procedings of the National Academy of Science 102, 7607.
        • Bracken, C.P., et al. 2005. Journal of Biological Chemistry 280, 14240.
        • Don J. Davidson, D.J., et al. 2005. Cancer Research 65, 4663.
        • Dufour, E.K., et al. 2005. Protein Science 14, 303.
        • Hoffmeister, M., et al. 2005. Journal of Biological Chemistry 280, 4329.
        • Hymowitz, S.G., et al. 2005. Journal of Biological Chemistry 280, 7218.
        • Kani, K., et al. 2005. Journal of Biological Chemistry 280, 8238.
        • Katou, S., et al. 2005. Journal of Biological Chemistry 280, 39569.
        • Lara, M.V., et al. 2005. Plant and Cell Physiology 46, 997.
        • Lo, K.W., et al. 2005. Journal of Biological Chemistry 280, 8172.
        • Ran X., and Song J., 2005. Journal of Biological Chemistry 280, 19205.
        • Schilling, O., et al. 2005. Journal of Biological Chemistry 280, 17857.
        • Takahashi-Terada, A., et al. 2005. Journal of Biological Chemistry 280, 11798.
        • Yoshida S., and Parniske M., 2005. Journal of Biological Chemistry 280, 9203.
        • Holland M.C.H., and Lambris J.D., 2004. Journal of Immunology 172, 349.
        • Ichinoe, A., et al. 2004. i>Nucleic Acids Research 32, 477.
        • Mancini, E.J., et al. 2004.Acta Crystallographica D60, 588.
        • Raschle,M., et al. 2004. Journal of Biological Chemistry 279, 51973.
        • Trabbic-Carlson, K., et al. 2004. Protein Engineering Design and Selection 17, 57.
        • Marina V. Backer, M.V., et al. 2003. Protein Expression and Purification 26, 455.
        • Perrin, M.H., et al. 2003. Journal of Biological Chemistry 278, 15595.
        • Rosenblum, M.G., et al. 2003. Cancer Research 63, 3995.
        • Lobel, L., et al. 2002. Protein Expression and Purification 25, 124.
        • Koffa, M.D., et al. 2001. European Molecular Biology Organization Journal 20, 5769.
        • Lauber, T., et al. 2001. Protein Expression and Purification 22, 108.
        • Lobel, L.I., et al. 2001. Endocrine 14, 205.
        • Huang, J.D., et al. 1999. Nature 397, 267.
        • Becker, S., et al. 1998. nature 394, 145.
        • Xu, G.L., and Bestor T.H., 1997. Nature Genetics 17, 376.
        • Protocolos de usuario

          Cargo
          TB053 Academic and Non-profit Laboratory Assurance Letter
          TB055 pET System Manual

          Mapa vectorial

          Cargo
          TB122VM pET-32a-c(+) Vector Map

          Secuencia vectorial

          Cargo
          pET-32a(+) Sequence

          Productos y aplicaciones relacionados

          Related Products

           Número de referencia Descripción  
          69016 pET-32b(+) DNA - Novagen Precios y disponibilidad
          69017 pET-32c(+) DNA - Novagen Precios y disponibilidad
          70785 pET Trx Fusion System 32 - Novagen Precios y disponibilidad
          70786 pET Trx Fusion System 32 plus Competent Cells Precios y disponibilidad

          Categorías

          Life Science Research > Genomic Analysis > Transfection and Protein Expression > Bacterial Expression > Bacterial Expression Vectors